ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Efficacy and Safety of Mirodenafil, A New Oral Phosphodiesterase Type 5 Inhibitor, for Treatment of Erectile Dysfunction
Version of Record online: 14 JUL 2008
© 2008 International Society for Sexual Medicine
The Journal of Sexual Medicine
Volume 5, Issue 11, pages 2672–2680, November 2008
How to Cite
Paick, J.-S., Ahn, T. Y., Choi, H. K., Chung, W.-S., Kim, J. J., Kim, S. C., Kim, S. W., Lee, S. W., Min, K. S., Moon, K. H., Park, J. K., Park, K., Park, N. C., Suh, J.-K., Yang, D. Y. and Jung, H.-G. (2008), ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Efficacy and Safety of Mirodenafil, A New Oral Phosphodiesterase Type 5 Inhibitor, for Treatment of Erectile Dysfunction. Journal of Sexual Medicine, 5: 2672–2680. doi: 10.1111/j.1743-6109.2008.00945.x
- Issue online: 3 NOV 2008
- Version of Record online: 14 JUL 2008
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!